Abstract #0618

In vivo MRI detection of β-amyloid pathologies at early and late stages of Alzheimer’s disease

Celia M. Dong^1,2, Anthea To^1,2, Shuai Guo^1,2, Kannie W. Y. Chan^3,4,5, Alex T. L. Leong^1,2, and Ed X. Wu^1,2

¹Laboratory of Biomedical Imaging and Signal Processing, The University of Hong Kong, Hong Kong, China, ²Department of Electrical and Electronic Engineering, The University of Hong Kong, Hong Kong, China, ³Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, China, ⁴F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, MD, United States, ⁵Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

Early diagnosis of Alzheimer’s disease (AD) is crucial. However, there is a lack of effective diagnostic tools to detect AD at the early stage. Early stage β-amyloid (Aβ) oligomers (AβOs) and late stage Aβ plaques are the pathological hallmarks of AD brains. Recently, we have synthesized a novel curcumin-conjugated magnetic nanoparticle (Cur-MNP) to target Aβ pathologies, visualized in MRI. In this study, we investigated the in vivo feasibility of Cur-MNPs to detect the Aβ pathologies at early and late stages of AD progression, and performed immunohistology to validate the specific targeting of Aβ pathologies.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.